Global Hyperimmune Globulins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 143714
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 119
  • list Pharmaceuticals and Healthcare

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Scope of the Report:

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

The worldwide market for Hyperimmune Globulins is expected to grow at a CAGR of roughly 11.6% over the next five years, will reach 140 million US$ in 2024, from 82 million US$ in 2019, according to a new study.

This report focuses on the Hyperimmune Globulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

CSL Behring

Grifols

Biotest

Kedrion

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

ADMA Biologics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hepatitis B Immunoglobulins

Rabies Immunoglobulins

Tetanus Immunoglobulins

Rho(D) Immunoglobulins

Others

Market Segment by Applications, can be divided into

Government Institutions

Private Sector

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Hyperimmune Globulins product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Hyperimmune Globulins, with price, sales, revenue and global market share of Hyperimmune Globulins in 2017 and 2018.

Chapter 3, the Hyperimmune Globulins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hyperimmune Globulins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Hyperimmune Globulins Introduction

1.2 Market Analysis by Type

1.2.1 Hepatitis B Immunoglobulins

1.2.2 Rabies Immunoglobulins

1.2.3 Tetanus Immunoglobulins

1.2.4 Rho(D) Immunoglobulins

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Government Institutions

1.3.2 Private Sector

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 CSL Behring

2.1.1 Business Overview

2.1.2 Hyperimmune Globulins Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Grifols

2.2.1 Business Overview

2.2.2 Hyperimmune Globulins Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Biotest

2.3.1 Business Overview

2.3.2 Hyperimmune Globulins Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Kedrion

2.4.1 Business Overview

2.4.2 Hyperimmune Globulins Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 CBPO

2.5.1 Business Overview

2.5.2 Hyperimmune Globulins Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Emergent (Cangene)

2.6.1 Business Overview

2.6.2 Hyperimmune Globulins Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Kamada

2.7.1 Business Overview

2.7.2 Hyperimmune Globulins Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 CNBG

2.8.1 Business Overview

2.8.2 Hyperimmune Globulins Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Hualan Bio

2.9.1 Business Overview

2.9.2 Hyperimmune Globulins Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Shanghai RAAS

2.10.1 Business Overview

2.10.2 Hyperimmune Globulins Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Sichuan Yuanda Shuyang

2.11.1 Business Overview

2.11.2 Hyperimmune Globulins Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 ADMA Biologics

2.12.1 Business Overview

2.12.2 Hyperimmune Globulins Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Hyperimmune Globulins Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Hyperimmune Globulins Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Hyperimmune Globulins Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Hyperimmune Globulins Manufacturer Market Share in 2018

3.3.2 Top 6 Hyperimmune Globulins Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Hyperimmune Globulins Market Analysis by Regions

4.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Regions

4.1.1 Global Hyperimmune Globulins Sales and Market Share by Regions (2014-2019)

4.1.2 Global Hyperimmune Globulins Revenue and Market Share by Regions (2014-2019)

4.2 North America Hyperimmune Globulins Sales and Growth Rate (2014-2019)

4.3 Europe Hyperimmune Globulins Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2014-2019)

4.5 South America Hyperimmune Globulins Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)

5 North America Hyperimmune Globulins by Country

5.1 North America Hyperimmune Globulins Sales, Revenue and Market Share by Country

5.1.1 North America Hyperimmune Globulins Sales and Market Share by Country (2014-2019)

5.1.2 North America Hyperimmune Globulins Revenue and Market Share by Country (2014-2019)

5.2 United States Hyperimmune Globulins Sales and Growth Rate (2014-2019)

5.3 Canada Hyperimmune Globulins Sales and Growth Rate (2014-2019)

5.4 Mexico Hyperimmune Globulins Sales and Growth Rate (2014-2019)

6 Europe Hyperimmune Globulins by Country

6.1 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Country

6.1.1 Europe Hyperimmune Globulins Sales and Market Share by Country (2014-2019)

6.1.2 Europe Hyperimmune Globulins Revenue and Market Share by Country (2014-2019)

6.2 Germany Hyperimmune Globulins Sales and Growth Rate (2014-2019)

6.3 UK Hyperimmune Globulins Sales and Growth Rate (2014-2019)

6.4 France Hyperimmune Globulins Sales and Growth Rate (2014-2019)

6.5 Russia Hyperimmune Globulins Sales and Growth Rate (2014-2019)

6.6 Italy Hyperimmune Globulins Sales and Growth Rate (2014-2019)

7 Asia-Pacific Hyperimmune Globulins by Country

7.1 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Hyperimmune Globulins Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Hyperimmune Globulins Revenue and Market Share by Country (2014-2019)

7.2 China Hyperimmune Globulins Sales and Growth Rate (2014-2019)

7.3 Japan Hyperimmune Globulins Sales and Growth Rate (2014-2019)

7.4 Korea Hyperimmune Globulins Sales and Growth Rate (2014-2019)

7.5 India Hyperimmune Globulins Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2014-2019)

8 South America Hyperimmune Globulins by Country

8.1 South America Hyperimmune Globulins Sales, Revenue and Market Share by Country

8.1.1 South America Hyperimmune Globulins Sales and Market Share by Country (2014-2019)

8.1.2 South America Hyperimmune Globulins Revenue and Market Share by Country (2014-2019)

8.2 Brazil Hyperimmune Globulins Sales and Growth Rate (2014-2019)

8.3 Argentina Hyperimmune Globulins Sales and Growth Rate (2014-2019)

8.4 Colombia Hyperimmune Globulins Sales and Growth Rate (2014-2019)

9 Middle East and Africa Hyperimmune Globulins by Countries

9.1 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Hyperimmune Globulins Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Hyperimmune Globulins Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2014-2019)

9.3 Turkey Hyperimmune Globulins Sales and Growth Rate (2014-2019)

9.4 Egypt Hyperimmune Globulins Sales and Growth Rate (2014-2019)

9.5 Nigeria Hyperimmune Globulins Sales and Growth Rate (2014-2019)

9.6 South Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)

10 Global Hyperimmune Globulins Market Segment by Type

10.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Hyperimmune Globulins Sales and Market Share by Type (2014-2019)

10.1.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2014-2019)

10.2 Hepatitis B Immunoglobulins Sales Growth and Price

10.2.1 Global Hepatitis B Immunoglobulins Sales Growth (2014-2019)

10.2.2 Global Hepatitis B Immunoglobulins Price (2014-2019)

10.3 Rabies Immunoglobulins Sales Growth and Price

10.3.1 Global Rabies Immunoglobulins Sales Growth (2014-2019)

10.3.2 Global Rabies Immunoglobulins Price (2014-2019)

10.4 Tetanus Immunoglobulins Sales Growth and Price

10.4.1 Global Tetanus Immunoglobulins Sales Growth (2014-2019)

10.4.2 Global Tetanus Immunoglobulins Price (2014-2019)

10.5 Rho(D) Immunoglobulins Sales Growth and Price

10.5.1 Global Rho(D) Immunoglobulins Sales Growth (2014-2019)

10.5.2 Global Rho(D) Immunoglobulins Price (2014-2019)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2014-2019)

10.6.2 Global Others Price (2014-2019)

11 Global Hyperimmune Globulins Market Segment by Application

11.1 Global Hyperimmune Globulins Sales Market Share by Application (2014-2019)

11.2 Government Institutions Sales Growth (2014-2019)

11.3 Private Sector Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 Hyperimmune Globulins Market Forecast (2019-2024)

12.1 Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2019-2024)

12.2 Hyperimmune Globulins Market Forecast by Regions (2019-2024)

12.2.1 North America Hyperimmune Globulins Market Forecast (2019-2024)

12.2.2 Europe Hyperimmune Globulins Market Forecast (2019-2024)

12.2.3 Asia-Pacific Hyperimmune Globulins Market Forecast (2019-2024)

12.2.4 South America Hyperimmune Globulins Market Forecast (2019-2024)

12.2.5 Middle East and Africa Hyperimmune Globulins Market Forecast (2019-2024)

12.3 Hyperimmune Globulins Market Forecast by Type (2019-2024)

12.3.1 Global Hyperimmune Globulins Sales Forecast by Type (2019-2024)

12.3.2 Global Hyperimmune Globulins Market Share Forecast by Type (2019-2024)

12.4 Hyperimmune Globulins Market Forecast by Application (2019-2024)

12.4.1 Global Hyperimmune Globulins Sales Forecast by Application (2019-2024)

12.4.2 Global Hyperimmune Globulins Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Hyperimmune Globulins Picture

Table Product Specifications of Hyperimmune Globulins

Figure Global Sales Market Share of Hyperimmune Globulins by Types in 2018

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery